California's Cell/Gene Therapy Program Critized for Non-Scientific Priorities and Failing to Meet Urgent Needs

USC scientist sent his comments to CIRM board for Thursday public meeting

CIRM’s summary of the aims of its new preferences in awarding millions of dollars

A Southern California scientist has joined the small chorus of researchers publicly criticizing the new priorities and preferences of California’s taxpayer-backed $12 billion stem cell and gene therapy program.

“Non-scientific preferences” are driving some of the program’s f…